- 专利标题： ANTI-VIRAL COMPOUNDS
-
申请号： US14180886申请日： 2014-02-14
-
公开(公告)号： US20140315792A1公开(公告)日： 2014-10-23
- 发明人: Rolf Wagner , John K. Pratt , Dachun Liu , Michael D. Tufano , David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Dooner , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , David A. Betebenner , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , Yi Gao , Allan C. Krueger
- 申请人： AbbVie, Inc.
- 主分类号： C07K5/06
- IPC分类号： C07K5/06 ; C07D417/14 ; C07C33/26 ; C07D403/14 ; C07C205/19
摘要：
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
公开/授权文献
- US09006387B2 Anti-viral compounds 公开/授权日：2015-04-14
信息查询
